Hence, an important class of drugs that may possess the potential to diminish injurious effects on memory and cognition in AD refers to Ang II AT1R antagonists (ARBs), especially since studies have shown that elevated levels of both Ang II and AT1Rs were registered in the brains of AD patients [6,48]. The gene discussed is AGT; the disease is Alzheimer disease.